Table 2.
Summary of the perioperative parameters and surgical success of the two groups.
| LP; n = 22 | RALP; n = 24 | p-values | |
|---|---|---|---|
| OT in minutes | 242 ± 59 | 225 ± 3 9 | 0.25 |
| Intraoperative cystoscopy | 2/22 | 2/24 | 0.93 |
| Aberrant crossing vessels | 0/22 | 3/24 | 0.09 |
| Participation of surgeon-in-training | 7/22 | 12/24 | 0.21 |
| Conversion to open or placement of additional ports | Nil | Nil | NA |
| Intraoperative complications or blood transfusion | Nil | Nil | NA |
| Mean number of doses of oral acetominophen per patient | 3.8 ± 2.5 | 4.3 ± 3.2 | 0.55 |
| Mean number of doses of intramuscular narcotics per patient | 0.15 ± 0.50 | 0.04 ± 0.20 | 0.31 |
| LOS in days | 3.8 ± 1.3 | 3.0 ± 0.3 | 0.009 |
| Post-operative complications (%) | 4/22 (18) | 3/24 (13) | 0.59 |
| Clavien Grade I – II | Prolonged ileus = 1 Stent-related UTI = 3 | Stent-related UTI =2 | |
| Clavien Grade IIIb | Proximal migration of Double-J stent = 1 | ||
| Operative success (%) | 20/22 (91) | 23/24 (96) | 0.49 |
| Mean follow-up in months | 40 ± 16 | 23 ± 12 | <0.001 |
LP, laparoscopic pyeloplasty; RALP, robot-assisted laparoscopic pyeloplasty; OT, operative time; LOS, length of stay; UTI, urinary tract infection; NA, not applicable.